Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 9976
Country/Region: Vietnam
Year: 2015
Main Partner: Ministry of Health - Vietnam
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $5,774,007 Additional Pipeline Funding: $2,415,332

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $800,000
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $200,000
Care: Pediatric Care and Support (PDCS) $130,000
Laboratory Infrastructure (HLAB) $100,000
Strategic Information (HVSI) $300,000
Health Systems Strengthening (OHSS) $200,000
Testing: HIV Testing and Counseling (HVCT) $1,000,000
Sexual Prevention: Other Sexual Prevention (HVOP) $50,000
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $600,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $500,000
Treatment: Adult Treatment (HTXS) $1,800,000
Treatment: Pediatric Treatment (PDTX) $94,007
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 800
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 846
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 9,450
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 15,188
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 26,284
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 26,284
CARE_NEW Aggregated Age/sex: <15 Female 2016 64
CARE_NEW Aggregated Age/sex: <15 Male 2016 96
CARE_NEW Aggregated Age/sex: 15+ Female 2016 1,116
CARE_NEW Aggregated Age/sex: 15+ Male 2016 2,064
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 3,340
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 3,340
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 3,340
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 314
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 299
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 20,006
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 97,656
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 8,984
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 44,321
HTS_TST By Test Result: Negative 2016 28,305
HTS_TST By Test Result: Negative 2016 138,243
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 28,990
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 142,590
HTS_TST Sum of Aggregated Age/Sex <15 2016 613
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 28,990
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 141,977
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 28,990
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 142,590
HTS_TST Sum of Test Result disaggregates 2016 28,990
HTS_TST Sum of Test Result disaggregates 2016 142,590
HTS_TST_POS By Test Result: Positive 2016 685
HTS_TST_POS By Test Result: Positive 2016 4,347
KP_MAT Number of people who inject drugs (PWID) on medication assisted therapy (MAT) for at least 6 months 2016 5,300
KP_MAT Sex: Female 2016 270
KP_MAT Sex: Male 2016 5,030
KP_MAT Sum of Sex disaggregates 2016 5,300
KP_PREV By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2016 1,262
KP_PREV By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2016 23,675
KP_PREV By key population type: Men who have sex with men/Transgender (MSM/TG) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2016 462
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2016 32,750
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 62
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 245
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 46
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 233
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 93
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 140
PMTCT_ARV Sum of New and Current disaggregates 2016 233
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 613
PMTCT_STAT By: Known positives at entry 2016 12
PMTCT_STAT By: Known positives at entry 2016 177
PMTCT_STAT By: Number of new positives identified 2016 50
PMTCT_STAT By: Number of new positives identified 2016 47
PMTCT_STAT Number of new ANC and L&D clients 2016 14,266
PMTCT_STAT Number of new ANC and L&D clients 2016 63,395
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 14,266
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 58,574
PMTCT_STAT Sum of Positives Status disaggregates 2016 62
PMTCT_STAT Sum of Positives Status disaggregates 2016 224
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 26,284
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 23,667
TX_CURR Aggregated Age/Sex: <1 Female 2016 20
TX_CURR Aggregated Age/Sex: <1 Male 2016 18
TX_CURR Aggregated Age/Sex: 15+ Female 2016 9,105
TX_CURR Aggregated Age/Sex: 15+ Male 2016 14,338
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 25,002
TX_CURR Sum of Aggregated Age/Sex (<1 and 1-14) <15 2016 1,559
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 23,443
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 23,443
TX_NEW Aggregated Grouping by Age: <1 Male 2016 5
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2016 14
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2016 1,169
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2016 1,904
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 3,211
TX_NEW Sum of Aggregated Age/Sex disaggregates 2016 3,073
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 2,443
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 2,873
Cross Cutting Budget Categories and Known Amounts Total: $3
Human Resources for Health $1
Key Populations: MSM and TG $1
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Monitoring and evaluation of MSM/TG programs
Key Populations: Sex Workers $1
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Monitoring and evaluation of SW programs